Market closed
Korro Bio, Inc./$KRRO
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About Korro Bio, Inc.
Korro Bio Inc is a biopharmaceutical company with a mission to discover, develop, and commercialize a new class of genetic medicines based on editing RNA, enabling the treatment of both rare and highly prevalent diseases. It is generating a portfolio of differentiated programs that are designed to harness the body's natural RNA editing process to effect a precise yet transient single base edit. By editing RNA instead of DNA, Korro Bio is expanding the reach of genetic medicines by delivering additional precision and tunability.
Ticker
$KRRO
Sector
Trading on
Industry
Biotechnology
Headquarters
Employees
104
Website
Korro Bio, Inc. Metrics
BasicAdvanced
$135M
-
-$9.37
-
-
Price and volume
Market cap
$135M
52-week high
$28.49
52-week low
$13.38
Financial strength
Current ratio
8.792
Quick ratio
8.542
Long term debt to equity
27.105
Total debt to equity
27.906
Management effectiveness
Return on assets (TTM)
-25.65%
Return on equity (TTM)
-50.61%
Valuation
Price to revenue (TTM)
56.485
Price to book
0.84
Price to tangible book (TTM)
0.84
Price to free cash flow (TTM)
-1.645
Growth
Earnings per share change (TTM)
-82.35%
3-year earnings per share growth (CAGR)
23.80%
Korro Bio, Inc. News
AllArticlesVideos
Korro Appoints Biotech Industry Veteran, Loïc Vincent, Ph.D., as Chief Scientific Officer
GlobeNewsWire·5 days ago
Korro Reports Full Year 2024 Financial Results and Provides Business Updates
GlobeNewsWire·3 weeks ago
KRRO-110 Receives Orphan Drug Designation from U.S. FDA for Alpha-1 Antitrypsin Deficiency
GlobeNewsWire·3 weeks ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
FAQs
What’s the current market cap for Korro Bio, Inc. stock?
Korro Bio, Inc. (KRRO) has a market cap of $135M as of April 06, 2025.
What is the P/E ratio for Korro Bio, Inc. stock?
The price to earnings (P/E) ratio for Korro Bio, Inc. (KRRO) stock is 0 as of April 06, 2025.
Does Korro Bio, Inc. stock pay dividends?
No, Korro Bio, Inc. (KRRO) stock does not pay dividends to its shareholders as of April 06, 2025.
When is the next Korro Bio, Inc. dividend payment date?
Korro Bio, Inc. (KRRO) stock does not pay dividends to its shareholders.
What is the beta indicator for Korro Bio, Inc.?
Korro Bio, Inc. (KRRO) does not currently have a Beta indicator.